Valuation: GC Corp.

Market Cap 490B 346M 299M 280M 255M 480M 33.11B 487M 3.29B 1.29B 16.59B 1.3B 1.27B 55.18B P/E 2024
33.4x
P/E 2025 -10.4x
Enterprise Value 1,884B 1.33B 1.15B 1.08B 983M 1.85B 127B 1.87B 12.65B 4.96B 63.82B 5B 4.89B 212B EV / Sales 2024
0.83x
EV / Sales 2025 0.86x
Free-Float
43.96%
Yield 2024
2.89%
Yield 2025 -
11/06 GC Corp.(KOSE:A005250) dropped from KOSPI 200 Index CI
27/05 Green Cross Holdings to divest 460 billion won worth of stake in Curevo RE
15/05 GC Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
31/03 Green Cross Holdings Corporation acquired 22.08% stake in GREEN CROSS WellBeing Corporation from GC Biopharma Corp. for KRW 50.5 billion. CI
18/03 GC Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
11/02 Green Cross Holdings Corporation announces Annual dividend, payable on April 17, 2026 CI
14/11 Green Cross Holdings Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
14/08/25 Green Cross Holdings Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
19/06/25 Green Cross Holdings Corporation agreed to acquire an additional 23.56% stake in GC Care for KRW 71.9 billion. CI
15/05/25 Green Cross Holdings Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
18/03/25 Green Cross Holdings Corporation Reports Earnings Results for the Full Year Ended December 31, 2024 CI
14/11/24 Green Cross Holdings Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
06/11/24 China Resources Boya Bio-pharmaceutical Group Co.,Ltd completed the acquisition of 100% stake in Green Cross Hk Holdings Limited from Green Cross Holdings Corporation, Synaptic 1st Private Equity Fund and others for CNY 1.82 billion. CI
1 day+2.97%
1 week+1.13%
Current month+15.59%
1 month+11.63%
3 months-28.33%
6 months-32.01%
Current year-32.47%
1 week 10,440
Extreme 10440
10,850
1 month 8,630
Extreme 8630
10,950
Current year 8,630
Extreme 8630
18,010
1 year 8,630
Extreme 8630
18,010
3 years 8,630
Extreme 8630
18,490
5 years 8,630
Extreme 8630
35,100
10 years 8,630
Extreme 8630
56,300
Manager TitleAgeSince
Chief Executive Officer 52 01/03/2010
Chief Executive Officer 72 25/03/2010
Director of Finance/CFO 53 -
Director TitleAgeSince
Chairman 72 17/12/2010
Director/Board Member 76 01/03/2009
Director/Board Member 52 01/03/2010
Date Insider Type Main position Quantity % Market Cap.
25/4/25 Buy

Chief Executive Officer

1,334 0.0028%
25/4/25 Buy

Chief Executive Officer

3,191 0.0068%
25/4/25 Buy

Chief Executive Officer

6,748 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
+2.97%+1.13%-30.91%-21.82% 346M
+0.25%-3.96%+68.73%+120.06% 1,052B
+0.78%+0.21%+48.53%+50.78% 627B
+0.35%+0.95%+21.11%+66.86% 441B
+0.28%-4.56%+39.10%+38.05% 349B
+0.78%-2.68%+24.03%+37.32% 287B
+0.87%-3.59%-0.28%+7.12% 241B
+1.00%+0.52%+41.46%+58.95% 224B
-0.78%-4.49%-10.28%-54.13% 202B
+0.40%+4.40%+17.36%+81.59% 172B
Average +0.69%-0.97%+21.89%+38.48% 359.55B
Weighted average by Cap. +0.44%-1.70%+39.70%+63.87%

Financials

2024 2025
Net sales 2,205B 1.56B 1.35B 1.26B 1.15B 2.16B 149B 2.19B 14.81B 5.8B 74.7B 5.86B 5.73B 249B 2,451B 1.73B 1.5B 1.4B 1.28B 2.41B 166B 2.44B 16.46B 6.45B 83.06B 6.51B 6.37B 276B
Net income 24.03B 16.99M 14.67M 13.76M 12.54M 23.57M 1.62B 23.9M 161M 63.22M 814M 63.8M 62.42M 2.71B -69.51B -49.17M -42.45M -39.82M -36.27M -68.2M -4.7B -69.14M -467M -183M -2.36B -185M -181M -7.83B
Net Debt 1,042B 737M 636M 597M 544M 1.02B 70.47B 1.04B 7B 2.74B 35.31B 2.77B 2.71B 117B 1,394B 986M 851M 799M 727M 1.37B 94.28B 1.39B 9.36B 3.67B 47.23B 3.7B 3.62B 157B
Logo GC Corp.
Green Cross Holdings is a Korea-based holding company principally engaged in the manufacture and distribution of pharmaceuticals. The Company operates its business through five segments. The Pharmaceutical Manufacturing and Sale segment mainly manufactures and sells blood products, general pharmaceuticals, vaccines and over-the-counter (OTC) drugs. The Medical Service and System Development and Supply segment primarily provides healthcare services. The Diagnostic and Analysis segment mainly engages in blood diagnostics and genetic analysis business. The Leasing and Service Business segment is primarily involved in the real estate leasing and the management of affiliated group companies. The Other segment mainly operates livestock operation and other business.
Employees
144
Date Price Change Volume
14/08/26 KRW 10,750.00 +2.97% 57,675
13/08/26 KRW 10,440.00 -2.43% 103,786
12/08/26 KRW 10,700.00 -0.19% 96,955
11/08/26 KRW 10,720.00 +0.85% 66,845
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. A005250 Stock